LIGHTPATH TECHNOLOGIES INC-A (LPTH)

US5322578056 - Common Stock

4.14  +0.35 (+9.23%)

After market: 4.1586 +0.02 (+0.45%)

Fundamental Rating

2

LPTH gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 126 industry peers in the Electronic Equipment, Instruments & Components industry. LPTH may be in some trouble as it scores bad on both profitability and health. LPTH does not seem to be growing, but still is valued expensively.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

LPTH had negative earnings in the past year.
In the past year LPTH has reported a negative cash flow from operations.
LPTH had negative earnings in 4 of the past 5 years.
Of the past 5 years LPTH 4 years had a positive operating cash flow.

1.2 Ratios

With a Return On Assets value of -17.11%, LPTH is not doing good in the industry: 71.07% of the companies in the same industry are doing better.
LPTH has a worse Return On Equity (-28.15%) than 71.90% of its industry peers.
Industry RankSector Rank
ROA -17.11%
ROE -28.15%
ROIC N/A
ROA(3y)-10.4%
ROA(5y)-7.04%
ROE(3y)-16.56%
ROE(5y)-11.33%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of LPTH (28.53%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of LPTH has declined.
LPTH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.03%
GM growth 5Y-6.01%

More info and screens

2

2. Health

2.1 Basic Checks

LPTH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LPTH has more shares outstanding
Compared to 5 years ago, LPTH has more shares outstanding
LPTH has a better debt/assets ratio than last year.

2.2 Solvency

LPTH has an Altman-Z score of -0.79. This is a bad value and indicates that LPTH is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.79, LPTH is doing worse than 82.64% of the companies in the same industry.
LPTH has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
LPTH has a Debt to Equity ratio of 0.03. This is comparable to the rest of the industry: LPTH outperforms 58.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -0.79
ROIC/WACCN/A
WACC10.33%

2.3 Liquidity

LPTH has a Current Ratio of 1.73. This is a normal value and indicates that LPTH is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.73, LPTH is not doing good in the industry: 70.25% of the companies in the same industry are doing better.
LPTH has a Quick Ratio of 1.03. This is a normal value and indicates that LPTH is financially healthy and should not expect problems in meeting its short term obligations.
LPTH's Quick ratio of 1.03 is on the low side compared to the rest of the industry. LPTH is outperformed by 78.51% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.03

More info and screens

3

3. Growth

3.1 Past

The earnings per share for LPTH have decreased strongly by -83.33% in the last year.
The Revenue has decreased by -4.73% in the past year.
Measured over the past years, LPTH shows a decrease in Revenue. The Revenue has been decreasing by -1.23% on average per year.
EPS 1Y (TTM)-83.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-4.73%
Revenue growth 3Y-6.21%
Revenue growth 5Y-1.23%
Sales Q2Q%4%

3.2 Future

LPTH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.96% yearly.
LPTH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.17% yearly.
EPS Next Y27.36%
EPS Next 2Y7.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.61%
Revenue Next 2Y14.17%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

LPTH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LPTH. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.96%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LPTH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIGHTPATH TECHNOLOGIES INC-A

NASDAQ:LPTH (1/3/2025, 8:00:01 PM)

After market: 4.1586 +0.02 (+0.45%)

4.14

+0.35 (+9.23%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-06 2025-02-06/amc
Inst Owners39.89%
Inst Owner Change-1.67%
Ins Owners2.75%
Ins Owner Change0%
Market Cap164.19M
Analysts84
Price Target3.06 (-26.09%)
Short Float %0.22%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.24%
Min EPS beat(2)-26.04%
Max EPS beat(2)21.57%
EPS beat(4)1
Avg EPS beat(4)-24.65%
Min EPS beat(4)-71.57%
Max EPS beat(4)21.57%
EPS beat(8)3
Avg EPS beat(8)-21.03%
EPS beat(12)4
Avg EPS beat(12)-88.59%
EPS beat(16)5
Avg EPS beat(16)-102.8%
Revenue beat(2)1
Avg Revenue beat(2)0.44%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)2.04%
Revenue beat(4)1
Avg Revenue beat(4)-2.6%
Min Revenue beat(4)-5.87%
Max Revenue beat(4)2.04%
Revenue beat(8)4
Avg Revenue beat(8)-0.84%
Revenue beat(12)4
Avg Revenue beat(12)-4.64%
Revenue beat(16)7
Avg Revenue beat(16)-2.74%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-44.43%
EPS NY rev (1m)4.08%
EPS NY rev (3m)-56.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-11.01%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)-6.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.12
P/FCF N/A
P/OCF N/A
P/B 5.58
P/tB 8.45
EV/EBITDA N/A
EPS(TTM)-0.22
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.81
BVpS0.74
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.11%
ROE -28.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.53%
FCFM N/A
ROA(3y)-10.4%
ROA(5y)-7.04%
ROE(3y)-16.56%
ROE(5y)-11.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.03%
GM growth 5Y-6.01%
F-Score3
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 30.81%
Cap/Sales 4.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.73
Quick Ratio 1.03
Altman-Z -0.79
F-Score3
WACC10.33%
ROIC/WACCN/A
Cap/Depr(3y)65.37%
Cap/Depr(5y)71.5%
Cap/Sales(3y)6.94%
Cap/Sales(5y)7.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-83.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y27.36%
EPS Next 2Y7.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.73%
Revenue growth 3Y-6.21%
Revenue growth 5Y-1.23%
Sales Q2Q%4%
Revenue Next Year11.61%
Revenue Next 2Y14.17%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-112.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year61.27%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-281.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-187.19%
OCF growth 3Y-52.06%
OCF growth 5Y4.91%